Drug resistant tuberculosis in prisons in Azerbaijan: Case study

British Medical Journal

Volumn 316, Issue 7142, 1998, Pages 1423-1425

  Coninx, R ^a   Pfyffer, G E ^b   Mathieu, C ^c   Savina, D ^c   Debacker, M ^c   Jafarov, F ^d   Jabrailov, I ^d   Ismailov, A ^c   Mirzoev, F ^c   De Haller, R ^a   Portaels, F ^e  

^a International Committee of the Red Cross   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Intl Committee of the Red Cross   (Azerbaijan)

^d Central Penitentiary Hospital   (Azerbaijan)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; AZERBAIJAN; HUMAN; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PRISON; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 7144261068     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7142.1423     Document Type: Article

References (13)

1. World Health Organisation. Tuberculosis trends in central and eastern Europe and countries of the former USSR. Wkly Epidemiol Rec 1995;4:21-4.
2. Raviglione MC, Rieder HL, Styblo K, Khomenko AG, Esteves K, Kochi A. Tuberculosis trends in eastern Europe and the former USSR. Tubercle Lung Dis 1994;75:400-6.
3. Coninx R, Eshaya-Chauvin B, Reyes H. Tuberculosis in prisons. Lancet 1995;346:1238-9.
4. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe. Quarterly report (No 52). Saint Maurice, France: ECEMAIDS, 1996:11.
5. Khomenko AG. The course and outcome of pulmonary tuberculosis due to drug resistant mycobacteria. 17th Annual meeting. European Society for Mycobacteriology. Paris: Institut Pasteur, 1996.
6. Drobniewski F, Taylor E, Ignatenko N, Paul J, Conolly M, Nye P, et al. Tuberculosis in Siberia. I. An epidemiological and microbiological assessment. Tubercle Lung Dis 1996;77:199-206.
7. World Health Organisation. WHO report on the tuberculosis epidemic, 1995. Stop TB at the source. Geneva: WHO, 1995. (WHO/TB/95.183.)
8. International Union Against Tuberculosis and Lung Disease. Tuberculosis guide for low income countries. 4th ed. Paris : IUATLD, 1996.
9. World Health Organisation. Treatment of tuberculosis. Guidelines for national programmes. Geneva: WHO, 1993. (WHO/TB.91.161.)
10. Kent PT, Kubica G. Public health mycobacteriology. A guide for the level III laboratory. Atlanta: US Department of Health and Human Services, Centers for Disease Control, 1985.
11. Morgan MA, Horstmeier CD, De Young DR, Roberts GD. Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol 1983;18:384-8.
12. Inderlied CB, Nash K. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids. In: Lorian V, ed. Antibiotics in laboratory medicine. 4th ed. Baltimore: Williams and Wilkins, 1996:127-75.
13. Kluge H. TB programme in Siberia. Like a scene from an old movie. Contact 1997;45:24.